Skip to main navigation
  • HOME
  • ABOUT ENZON
  • ROYALTY PRODUCTS
  • INVESTORS & MEDIA

    Investor Relations

    • Press Releases
    • Corporate Governance
    • SEC Filings
    • Stock Quote
    • Stock Lookup
    • Contact Us
  • CONTACT US
  • Request Information
  • Email Alerts
  • Download Library
  • RSS News Feeds
Shareholder Tools
Downloads
Print

Downloads

May 20, 2008
Enzon Announces Clinical Data from PEG-SN38 and rhMBL Studies at ASCO 14.4 KB
May 07, 2008
Enzon Pharmaceuticals, Inc. Announces Plan to Spin-off Biotechnology Business 13 KB
May 07, 2008
Enzon Reports Strong First Quarter 2008 Results 23.5 KB
Apr 30, 2008
Enzon to Release First Quarter 2008 Earnings on Wednesday, May 7, 2008 9 KB
Apr 23, 2008
Cimzia(R), Utilizing Enzon's Pegylation Technology, Approved in the U.S. 11.8 KB
Apr 09, 2008
Enzon to Present Preclinical Data On HIF-1alpha antagonist at AACR 8.5 KB
Mar 17, 2008
Enzon's PEG-SN38 Featured in Clinical Cancer Research 12.6 KB
Feb 14, 2008
Enzon Reports Significant Progress on the Reduction of Its Debt 9.2 KB
Feb 14, 2008
Enzon Reports Solid 2007 Results 36.6 KB
Feb 12, 2008
Enzon Pharmaceuticals to Add New Independent Director to Board 9.6 KB

Pagination

  • First page « first
  • Previous page ‹ previous
  • …
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Current page 13
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • …
  • Next page next ›
  • Last page last »

©2025 Enzon Pharmaceuticals, Inc., All Rights Reserved.